Perbedaan Organon Pharma Indonesia Tbk. dan Wahana Ottomitra Multiartha Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Wahana Ottomitra Multiartha Tbk. diperdagangkan di Rp296 (kapitalisasi pasar 940 M, volume 24 jam 3,2 jt). Perbedaan utamanya: Wahana Ottomitra Multiartha Tbk. jauh lebih besar — sekitar 9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WOMF | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 940 M |
Volume | — | 3,2 jt |
Lot | — | 31,97 rb |
Perputaran | — | 980,29 jt |
Harga Rata-rata | — | 306,64 |
Nilai Transaksi | — | 980,29 jt |
Harga Ekuilibrium Indikatif | — | 296 |
Volume Ekuilibrium Indikatif | — | 244 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Wahana Ottomitra Multiartha Tbk (the Company) formerly PT Jakarta Tokyo Leasing, was established based on notarial deed No.179 dated March 23, 1982 of Kartini Muljadi SH, notary in Jakarta. The name was changed to PT Fuji Semeru Leasing on Dec 15 1982 and changed to PT Wahana Ometraco Multiartha on March 15, 2000. On November 30, 2004, the Company obtained the Effective Letter of the Registration Statement for the Initial Public Offering of Shares from the Chairman of the Capital Market Supervisory Agency (BAPEPAM) in its Letter No.S-3551/PM/2004. The Companys shares were listed on the Jakarta and Surabaya Stock Exchange (now Indonesia Stock Exchange) on December 13, 2004.
Selengkapnya di halaman WOMF →